Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

ICCBBA Expands Enterprise Grant Program: Total Funding Increased to $100,000 in 2025 to Enhance Global Patient Safety


News provided by

ICCBBA

Feb 11, 2025, 08:00 ET

Share this article

Share toX

Share this article

Share toX

ICCBBA Enterprise Grant 2025
ICCBBA Enterprise Grant 2025

REDLANDS, Calif., Feb. 11, 2025 /PRNewswire/ -- ICCBBA has released their annual Enterprise Grant. This year ICCBBA has increased the total fund to $100,000 USD. Each applicant can now request up to a maximum award of $50,000 USD, providing even greater support for impactful projects. 

Who is ICCBBA & What do They Do? 
ICCBBA is the international non-profit standards development organization dedicated to managing and developing the ISBT 128 Standard, the international information standard for the terminology, coding, and labeling of Medical Products of Human Origin (MPHO) e.g. blood, cells, tissues, human milk, organs. The organization plays a critical role in enhancing patient safety through the development and maintenance of this standard, as well as allocating globally unique identifiers to registered facilities. Since its establishment in 1995, over 3152 MPHO organizations from 77 countries have registered with ICCBBA. 

Opportunities with the Enterprise Grant 
Through the ICCBBA Enterprise Grant, ICCBBA supports initiatives focused on developing organizational capacity, particularly in electronic information management and traceability of MPHO. The grant aims to support projects operating at local, national, or regional levels, especially in resource-constrained settings, to enhance organizational infrastructure with an emphasis on safety, efficiency, and traceability. Each applicant can now request up to a maximum award of $50,000 USD, providing even greater support for impactful projects. By fostering safer and more efficient systems, the grant seeks to raise the overall quality of transfusion or transplantation services and aligns with ICCBBA's mission to enhance patient safety through the development and maintenance of international information standards for MPHO.  Organizations are encouraged to seize this opportunity to contribute to the broader goal of improving patient safety on a global scale.

Enterprise Grant Objectives

  • Building technical capacity in transfusion and/or transplantation activities for enhanced safety and efficiency.
  • Assisting establishments in achieving reliable traceability of all managed MPHO.
  • Enabling ICCBBA to fulfill its mission of globally enhancing patient safety through international information standards for MPHO.

Key Dates & Information 

Dates

Key Items

February 4, 2025

Application Period Opens

March 25, 2025

Workshop Application Information Session

April 30, 2025

Application Period Closes

May 2025

Recommendation from Selection Committee

June 2025

Announcement of Award(s), Conclude Grant Agreements, and Fund Transfer

Eligibility Criteria & Rules 
Open exclusively to providers of MPHO transfusion and/or transplantation services that are non-profit entities, public institutions, and/or governmental agencies. 

  • Funds must be utilized exclusively for non-commercial purposes aimed at enhancing the safe and efficient provision of MPHO transfusion and/or transplantation services.
  • Projects focusing on improving traceability, particularly in resource-limited settings, are strongly encouraged.
  • Projects funded by this grant are expected to be completed within 12 months of receiving approval.
  • All applications must be submitted in English.
  • Applicants must comply with all relevant regulations and agreements outlined in the grant guidelines.

The Evaluation Process and Rubric Scale 
Enterprise Grant applications will be evaluated based on the following criteria: 

  • Evaluation Questions (10 points)
  • Demonstration of Need (15 points)
  • Description of Project/Initiative (25 points)
  • Intended Goals and Outcomes (20 points)
  • Alignment of Budget to Description of Work and Goals/Outcomes (10 points)
  • Team Composition (10 points)
  • Sustainability of the Work (10 points)

Award Information 
Successful applicants will receive formal notification from ICCBBA via a Notice of Award (NoA) sent directly to the applicant organization's business email. Payment procedures vary based on the grant amount. Any unused funds must be returned to ICCBBA upon termination of the agreement. Grantees may request extensions in writing under specific circumstances. Grantees must provide written reports summarizing project progress within specified timeframes. 

Join ICCBBA's Live Application Workshop Session 
Learn more about the ICCBBA Enterprise Grant and gain valuable insights into the application process.

During the session, participants will: 

  • Gain valuable insights into the Enterprise Grant program.
  • Hear from a previous grant recipient about their experience and successes.
  • Learn more about the application process and key considerations.

Application and Submission Information 
Applicants can access the required package on the ICCBBA Grant Page or by emailing our helpdesk at [email protected].  Applicants must carefully follow all instructions and ensure that all required documents are duly completed in English. The application must include various sections covering organizational details, project management, project details, budget, and a declaration. Careful adherence to instructions is crucial. If applicants do not answer the evaluation questions, they will be disqualified. Incomplete or non-compliant applications will be ineligible.

Summary 
In conclusion, the Enterprise Grant initiative perfectly embodies ICCBBA's mission, creating a ripple effect that positively impacts global healthcare. As the application window opens, organizations are urged to seize this invaluable opportunity and play a vital role in advancing patient safety. ICCBBA's commitment to supporting initiatives in resource-constrained settings, especially those enhancing organizational capacity and electronic information management for MPHO traceability, underscores the importance of collaborative efforts in improving healthcare systems worldwide. Let us join hands and make a meaningful difference in patient care together. 

For more detailed information and application guidelines, visit the ICCBBA Grant Page and embark on a journey towards excellence in MPHO services.  

For a list of previous ICCBBA grantees, visit: ICCBBA Grants and Awards. 

Contact Information 
For inquiries and further information regarding the Enterprise Grant, please contact ICCBBA Grants at [email protected]. 

Stay connected, stay informed, and stay inspired with ICCBBA.  

Subscribe to our newsletter at: https://www.isbt128.org/newsletter    

About ICCBBA:   
ICCBBA is the international standards development organization responsible for the management and development of the ISBT 128 Standard. 

The acronym ISBT was originally derived from the important role played by the International Society of Blood Transfusion in the development of the standard. Today it expands as Information Standard for Blood and Transplant. The number 128 reflects the 128 characters of the ISO/IEC 646 7-bit character set. The acronym ICCBBA is derived from the International Council for Commonality in Blood Banking Automation. 

For More Information  
About ICCBBA:  
https://www.isbt128.org/  
Press Contact:  
Email: [email protected]  

SOURCE ICCBBA

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Forum 30: Advancing Global Standards for Medical Products of Human Origin

Forum 30: Advancing Global Standards for Medical Products of Human Origin

The International Council for Commonality in Blood Banking Automation ("ICCBBA"), in partnership with the Italian national competent authority for...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.